赛诺医疗科学技术股份有限公司关于公司产品在海外获得注册证的自愿性披露公告 赛诺医疗于2026年1月收到通知，公司HT Supreme药物洗脱支架系统、SC HONKYTONK冠脉球囊扩张 导管及NC ROCKSTAR非顺应性球囊扩张导管获得哈萨克斯坦共和国卫生部的注册批准。上述产品已在 中国、美国、日本、欧洲等多个国家和地区取得注册证。此次注册获批将有助于公司产品在海外市场的 推广和销售，但其未来业绩影响存在政策、市场环境及汇率波动等不确定性。 截至2026年1月9日收盘，赛诺医疗(688108)报收于22.68元，上涨0.27%，换手率7.17%，成交量29.82万 手，成交额6.69亿元。 当日关注点 交易信息汇总 资金流向 1月9日主力资金净流出2082.77万元；游资资金净流入1709.91万元；散户资金净流入372.86万元。 公司公告汇总 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：1月9日主力资金净流出2082.77万元，显示主力短期谨慎态度。 来自公司公告汇总：赛诺医疗三款产品获哈萨克斯坦注册批 ...

公司公告汇总 赛诺医疗科学技术股份有限公司关于公司产品在海外获得注册证的自愿性披露公告 交易信息汇总 龙虎榜上榜 沪深交易所2026年1月5日公布的交易公开信息显示，赛诺医疗（688108）因有价格涨跌幅限制的日收盘 价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。 截至2026年1月9日收盘，赛诺医疗（688108）报收于22.68元，较上周的19.24元上涨17.88%。本周，赛 诺医疗1月6日盘中最高价报25.25元。1月5日盘中最低价报19.75元。本周共计1次涨停收盘，无跌停收盘 情况。赛诺医疗当前最新总市值94.36亿元，在医疗器械板块市值排名42/127，在两市A股市值排名 2132/5182。 本周关注点 赛诺医疗于2026年1月收到通知，公司HT Supreme药物洗脱支架系统、SC HONKYTONK冠脉球囊扩张 导管及NC ROCKSTAR非顺应性球囊扩张导管获得哈萨克斯坦共和国卫生部的注册批准。上述产品已在 中国、美国、日本、欧洲等多个国家和地区取得注册证。此次注册获批将有助于公司产品在海外市场的 推广和销售，但其未来业绩影响存在政策、市场环境及汇率波动等不确 ...

Market Overview - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index rose by 1.02% to 12907.83. The ChiNext Index increased by 2.14% to 3044.69, and the STAR 50 Index gained 0.99% to 1315.04 [1][8]. Industry Dynamics - During the Double Eleven shopping festival, the online sales of smart locks in China decreased by 26% year-on-year, with sales volume at 1.375 million units and sales revenue at 1.57 billion yuan, down 29.3% compared to the previous year [28][29]. - In September, the electric two-wheeler industry saw leading smart brands dominate the online market, with Yadi holding a market share of 22.6%, while Ninebot and Niu accounted for 27.6% and 23.5% respectively [30][31]. - The number of breeding sows in China was reported at 39.9 million as of the end of October, a decrease of 450,000 from the previous month, indicating a significant acceleration in the culling process due to low prices and production control [33][34]. - Alibaba's CEO stated that an AI bubble is unlikely in the next three years, as demand for AI resources is expected to exceed supply [35][36]. - Foxconn announced plans to expand operations in Wisconsin, USA, with a focus on AI infrastructure, investing an additional $569 million and creating 1,374 new jobs [37][38]. Company Updates - Sino Medical (688108.SH) received regulatory approval for its HT Supreme drug-eluting stent system in Pakistan, which is designed for patients with symptomatic coronary artery disease [39][40]. - Fuling Mustard (002507.SZ) reported successful expansion in the catering channel, with a projected growth rate exceeding 20% this year [41][42]. - Baoli Food (603170.SH) is actively expanding into new retail channels, having entered major platforms like Sam's Club and Hema [43][44]. - Titan Technology (688133.SH) announced a joint investment in a detection service and equipment company, aiming to enhance its laboratory service capabilities [45][46]. - Times New Material (600458.SH) plans to increase capital in its wholly-owned subsidiary in Vietnam to enhance competitiveness in the renewable energy sector, with an investment of approximately 45.846 million yuan [47][48].

赛诺医疗公告，公司于近日收到通知，递交的HT Supreme 药物洗脱支架系统注册申报资料获得巴基斯 坦药品监管局（DRAP）的批准。HT Supreme 药物洗脱支架系统是我国支架厂商自主研发的首个在中 国、美国、日本、欧洲同步进行支架上市前临床研究并在前述国家和地区申请产品注册的心脏支架产 品，于2019年12月获得欧盟CE认证，于2020年12月获得中国国家药监局颁发的《医疗器械注册证》。 ...